Bloom Burton Analyst Ratings & Stock Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Bloom Burton. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Bloom Burton.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
7/10/2019Bloom BurtonDowngradesCannTrust (CTST)Buy -> HoldHighView Rating Details  Share on Twitter  Share on StockTwits
7/3/2019Bloom BurtonReiteratesPediapharm (MDP)AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
5/16/2019Bloom BurtonDowngradesNuvo Pharmaceuticals (NRI)Buy -> HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
5/15/2019Bloom BurtonUpgradesCannTrust (CTST)Accumulate -> BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
4/1/2019Bloom BurtonReiteratesNuvo Pharmaceuticals (NRI)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/29/2019Bloom BurtonReiteratesCannTrust (CTST)AccumulateMediumView Rating Details  Share on Twitter  Share on StockTwits
3/20/2019Bloom BurtonReiteratesCipher Pharmaceuticals (CPH)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/15/2019Bloom BurtonReiteratesAdvanz Pharma (CXRXF)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
2/26/2019Bloom BurtonDowngradesClementia Pharmaceuticals (CMTA)Buy -> HoldLowView Rating Details  Share on Twitter  Share on StockTwits
12/16/2018Bloom BurtonReiteratesClementia Pharmaceuticals (CMTA)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018Bloom BurtonDowngradesNovelion Therapeutics (NVLN)Accumulate -> HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Bloom BurtonReiteratesKnight Therapeutics (GUD)AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
7/6/2018Bloom BurtonReiteratesBELLUS Health (BLU)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/26/2018Bloom BurtonUpgradesNuvo Pharmaceuticals (NRI)Accumulate -> BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018Bloom BurtonReiteratesBiosyent (RX)AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
1/18/2018Bloom BurtonUpgradesESSA Pharma (EPI)Hold -> BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
1/18/2018Bloom BurtonUpgradesESSA Pharma (EPIX)Hold -> BuyHighView Rating Details  Share on Twitter  Share on StockTwits
11/3/2017Bloom BurtonDowngradesNuvo Pharmaceuticals (NRI)Buy -> AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
10/25/2017Bloom BurtonReiteratesHamilton Thorne (HTL)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
9/12/2017Bloom BurtonDowngradesESSA Pharma (EPIX)Buy -> HoldLowView Rating Details  Share on Twitter  Share on StockTwits
8/14/2017Bloom BurtonDowngradesCipher Pharmaceuticals (CPH)Buy -> HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
7/14/2017Bloom BurtonDowngradesCRH Medical (CRH)Buy -> AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
7/14/2017Bloom BurtonDowngradesCRH Medical (CRHM)Buy -> AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
6/19/2017Bloom BurtonReiteratesNovelion Therapeutics (NVLN)AccumulateLowView Rating Details  Share on Twitter  Share on StockTwits
5/18/2017Bloom BurtonReiteratesESSA Pharma (EPIX)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
5/15/2017Bloom BurtonUpgradesNuvo Pharmaceuticals (NRI)Hold -> BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/12/2017Bloom BurtonUpgradesCipher Pharmaceuticals (CPH)Hold -> BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/9/2017Bloom BurtonDowngradesNuvo Pharmaceuticals (NRI)Accumulate -> HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
3/1/2017Bloom BurtonReiteratesBELLUS Health (BLU)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/24/2017Bloom BurtonDowngradesCRH Medical (CRH)Buy -> AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
2/13/2017Bloom BurtonReiteratesBiosyent (RX)AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
2/13/2017Bloom BurtonReiteratesCipher Pharmaceuticals (CPH)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
1/9/2017Bloom BurtonUpgradesArbutus Biopharma (ABUS)Accumulate -> BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
12/22/2016Bloom BurtonInitiatesXenon Pharmaceuticals (XENE)Buy $14.50N/AView Rating Details  Share on Twitter  Share on StockTwits
12/14/2016Bloom BurtonReiteratesArbutus Biopharma (ABUS)AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
11/10/2016Bloom BurtonReiteratesKnight Therapeutics (GUD)AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2016Bloom BurtonDowngradesConcordia International (CXRX)Hold -> SellN/AView Rating Details  Share on Twitter  Share on StockTwits
11/4/2016Bloom BurtonReiteratesTrillium Therapeutics (TRIL)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/4/2016Bloom BurtonReiteratesAurinia Pharmaceuticals (AUP)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/4/2016Bloom BurtonReiteratesAurinia Pharmaceuticals (AUPH)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2016Bloom BurtonReiteratesNuvo Pharmaceuticals (NRI)AccumulateN/AView Rating Details  Share on Twitter  Share on StockTwits
10/28/2016Bloom BurtonReiteratesCRH Medical (CRH)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
10/26/2016Bloom BurtonReiteratesConcordia International (CXRX)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
10/13/2016Bloom BurtonReiteratesProMetic Life Sciences (PLI)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
5/3/2013Bloom BurtonRaises TargetAchieve Life Sciences (ACHV)Buy$200.00 -> $250.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/8/2013Bloom BurtonRaises TargetAchieve Life Sciences (ACHV)$180.00 -> $200.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/18/2012Bloom BurtonDowngradesOncolytics Biotech (ONC)Buy -> HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
6/25/2012Bloom BurtonDowngradesTheratechnologies (THERF)Hold -> Sell$2.50 -> $0.75N/AView Rating Details  Share on Twitter  Share on StockTwits
5/4/2012Bloom BurtonLowers TargetAchieve Life Sciences (ACHV)Buy$190.00 -> $180.00N/AView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Saturday at 02:20 PM ET.

MarketBeat Community Rating for Bloom Burton

Community Ranking:  1.9 out of 5 (star half star)
Outperform Votes:  14,713 (Vote Outperform)
Underperform Votes:  24,994 (Vote Underperform)
Total Votes:  39,707
MarketBeat's community ratings are surveys of what our community members think about Bloom Burton and other research firms. Vote "Outperform" if you believe Bloom Burton's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Bloom Burton's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel